| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.5 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.5 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |